But did you look at the balance sheet? This company has currently the market cap of a shell and just 200M shares issued, while having more than 1M$ in revenues, a net income and a cash flow that is going to become positive as soon as a few revenues from the LifeStem operations come in (and they already started cell collection, as advertised on magazines).
The otc is full of pos trading at a 100 times bigger market cap.
The thing you people fail to realize is: until this "company" gets close to around 20M in revs and making money, it won't be considered much of anything by anybody, except traders gambling in speculation.
The risk here is ENORMOUS.
I just hope you longs don't lose everything. A lot of money has been lost in stocks especially the OTCBB.
The price action speaks volumes. There may be a short lived bounce here, thats about all.
News 
Market Data 
Discover 
